4-MORPHOLIN-4-YL-4-OXO-BUTYRIC ACID

CAS67900-19-0

4-MORPHOLIN-4-YL-4-OXO-BUTYRIC ACID (CAS 67900-19-0, C8H13NO4) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.

Chemical structure of 4-MORPHOLIN-4-YL-4-OXO-BUTYRIC ACID
C8H13NO4 · 187.19 g/mol
CAS No.
67900-19-0
Formula
C8H13NO4
Mol. weight
187.19 g/mol

Chemical Specifications

Identifiers

CAS number 67900-19-0
Product name 4-MORPHOLIN-4-YL-4-OXO-BUTYRIC ACID
Chinese name 4-吗啉-4-基-4-氧代丁酸
Synonyms AKOS BBS-00001411
Chinese synonyms 4-吗啉-4-基-4-氧代丁酸; 4-(4-吗啉基)-4-氧代丁酸
Molecular formula C8H13NO4
Molecular weight 187.19 g/mol

Physical and chemical properties

Boiling Point 208 ( ℃ )

Packaging, Storage & Transport

Available pack sizes 5kg, 1kg, 500g, 100g, 50g, 10g

Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.

Frequently Asked Questions

What is the CAS number of 4-MORPHOLIN-4-YL-4-OXO-BUTYRIC ACID?

The CAS Registry Number of 4-MORPHOLIN-4-YL-4-OXO-BUTYRIC ACID is 67900-19-0. 4-MORPHOLIN-4-YL-4-OXO-BUTYRIC ACID is also known as AKOS BBS-00001411.

What is the molecular formula and molecular weight of 4-MORPHOLIN-4-YL-4-OXO-BUTYRIC ACID?

The molecular formula of 4-MORPHOLIN-4-YL-4-OXO-BUTYRIC ACID is C8H13NO4, and its molecular weight is 187.19 g/mol.

How can I request a quotation for 4-MORPHOLIN-4-YL-4-OXO-BUTYRIC ACID?

Send an inquiry for 4-MORPHOLIN-4-YL-4-OXO-BUTYRIC ACID (CAS 67900-19-0) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.

Request a Quote for 4-MORPHOLIN-4-YL-4-OXO-BUTYRIC ACID

Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.

Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.